Pemphigus refers to a group of skin disorders that cause blistering and sores on the skin or mucous membranes of the mouth, nose, throat or genital region. The onset of disease is usually in ...

Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin. Pemphigus is ...

Pemphigus vulgaris is a chronic blistering disease. Clinically it is characterized by painful intra-epidermal bullae and superficial vesicles involving both the skin and mucosal areas. The diagnosis ...

This is a rare autoimmune skin disorder that occurs when your immune system starts attacking healthy epidermis cells (the top layer of your skin). Pemphigus can manifest itself as blisters and sores ...

Significantly more patients with moderate-to-severe pemphigus sustained their complete remission with rituximab (Rituxan) than with mycophenolate mofetil (MMF), a randomized trial showed. At 1 year, ...

Pemphigus, which is caused by autoantibodies, and bullous impetigo (including its generalized form, the staphylococcal scalded-skin syndrome), which is caused by Staphylococcus aureus, are seemingly ...

IN the consideration of vesiculating and bullous eruptions of the oral mucosa, insufficient attention has been given to benign mucous-membrane pemphigus as a distinct clinical entity. Also, in many ...

Pemphigus vulgaris is a rare autoimmune disease that causes painful blistering on mucous membranes like the mouth, eyes, or genitals. It can cause serious complications if it isn’t treated. If you ...

Pemphigus vulgaris is a rare autoimmune condition that causes painful blistering on the skin and mucous membranes. These blisters commonly appear in the mouth and are prone to bursting easily, which ...

(HealthDay)—For patients with pemphigus vulgaris, rituximab is superior to mycophenolate mofetil for producing sustained complete remission at 52 weeks, according to a study published online May 19 in ...